Qin YR - Search Results

1

Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis.

Xu WW, Liao L, Dai W, Zheng CC, Tan XP, He Y, Zhang QH, Huang ZH, Chen WY, Qin YR, Chen KS, He ML, Law S, Lung ML, He QY, Li B. Xu WW, et al. Among authors: qin yr. EBioMedicine. 2023 Jun;92:104587. doi: 10.1016/j.ebiom.2023.104587. Epub 2023 May 5. EBioMedicine. 2023. PMID: 37149929 Free PMC article.

2

CRISPR/Cas9 system: recent applications in immuno-oncology and cancer immunotherapy.

Chen C, Wang Z, Qin Y. Chen C, et al. Exp Hematol Oncol. 2023 Nov 14;12(1):95. doi: 10.1186/s40164-023-00457-4. Exp Hematol Oncol. 2023. PMID: 37964355 Free PMC article. Review.

3

DNA Methylation: From Cancer Biology to Clinical Perspectives.

Chen C, Wang Z, Ding Y, Wang L, Wang S, Wang H, Qin Y. Chen C, et al. Front Biosci (Landmark Ed). 2022 Dec 20;27(12):326. doi: 10.31083/j.fbl2712326. Front Biosci (Landmark Ed). 2022. PMID: 36624943 Free article. Review.

4

PHF5A promotes esophageal squamous cell carcinoma progression via stabilizing VEGFA.

Chang Z, Jia Y, Gao M, Song L, Zhang W, Zhao R, Yu D, Liu X, Li J, Qin Y. Chang Z, et al. Biol Direct. 2024 Mar 1;19(1):19. doi: 10.1186/s13062-023-00440-3. Biol Direct. 2024. PMID: 38429756 Free PMC article.

5

The deubiquitinase USP7 and E3 ligase TRIM21 regulate vasculogenic mimicry and malignant progression of RMS by balancing SNAI2 homeostasis.

Zhang R, Zhang D, Han F, Song X, Zhang Y, Zhang J, Zhu Q, Qin Y. Zhang R, et al. J Exp Clin Cancer Res. 2024 May 4;43(1):135. doi: 10.1186/s13046-024-03056-1. J Exp Clin Cancer Res. 2024. PMID: 38702792 Free PMC article.

6

Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients.

Jia B, Xia P, Dong J, Feng W, Wang W, Liu E, Jiang G, Qin Y. Jia B, et al. Front Oncol. 2023 Jan 17;12:1086908. doi: 10.3389/fonc.2022.1086908. eCollection 2022. Front Oncol. 2023. PMID: 36741696 Free PMC article.

7

Long-term effect of hospital volume on the postoperative prognosis of 158,618 patients with esophageal squamous cell carcinoma in China.

Lei LL, Song X, Zhao XK, Xu RH, Wei MX, Sun L, Wang PP, Yang MM, Hu JF, Zhong K, Han WL, Han XN, Fan ZM, Wang R, Li B, Zhou FY, Wang XZ, Zhang LG, Bao QD, Qin YR, Chang ZW, Ku JW, Yang HJ, Yuan L, Ren JL, Li XM, Wang LD. Lei LL, et al. Among authors: qin yr. Front Oncol. 2023 Feb 16;12:1056086. doi: 10.3389/fonc.2022.1056086. eCollection 2022. Front Oncol. 2023. PMID: 36873301 Free PMC article.

8

NALCN is a potential biomarker and therapeutic target in human cancers.

He J, Xu J, Chang Z, Yan J, Zhang L, Qin Y. He J, et al. Front Genet. 2023 Apr 19;14:1164707. doi: 10.3389/fgene.2023.1164707. eCollection 2023. Front Genet. 2023. PMID: 37152978 Free PMC article.

9

Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma.

Chen C, Wang Z, Ding Y, Qin Y. Chen C, et al. Front Immunol. 2023 Feb 10;14:1133308. doi: 10.3389/fimmu.2023.1133308. eCollection 2023. Front Immunol. 2023. PMID: 36845131 Free PMC article. Review.

10

Chimeric antigen receptor T-cell therapy for multiple myeloma.

Wang Z, Chen C, Wang L, Jia Y, Qin Y. Wang Z, et al. Front Immunol. 2022 Dec 22;13:1050522. doi: 10.3389/fimmu.2022.1050522. eCollection 2022. Front Immunol. 2022. PMID: 36618390 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page